2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Revenue | $156M | $177M | $225M | $263M | $196M |
Cost of Revenue | $106M | $118M | $153M | $179M | $136M |
Gross Profit | $50M | $59M | $72M | $84M | $60M |
Gross Profit % | 32% | 33% | 32% | 32% | 31% |
R&D Expenses | $0 | $0 | $0 | $0 | $0 |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Net Income | -$1.8M | $1.7M | $18M | $22M | $61K |
Dep. & Amort. | $3.4M | $3.4M | $3.4M | $3.7M | $4.3M |
Def. Tax | -$7K | -$1K | -$4M | -$138K | -$1M |
Stock Comp. | $683K | $675K | $654K | $936K | $1.3M |
Chg. in WC | -$1.3M | -$6M | -$17M | -$35M | $1.2M |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | $31M | $43M | $35M | $25M | $24M |
ST Investments | $16M | $0 | $5M | $0 | $0 |
Cash & ST Inv. | $47M | $43M | $40M | $25M | $24M |
Receivables | $20M | $25M | $30M | $30M | $25M |
Inventory | $57M | $64M | $80M | $110M | $110M |
Q3 FY25 consolidated net sales increased 2.7% year-over-year to $53.8M, with strong growth in semiconductor wafer fab sales (+139%) and Canvas sales (+39.5%), partially offset by a $1M decrease in healthcare sales and a $2.2M decline in Green Energy Solutions (GES) sales due to project timing.
Gross margin improved to 31% (up 150 bps YoY), driven by margin expansion in PMT and GES segments; non-GAAP operating profit rose to $2.2M (from $1M YoY), while a one-time $4.9M loss on healthcare asset sale led to a GAAP net loss of $2.1M.
The company ended Q3 with $36.7M in cash and no debt, aided by the $8.2M healthcare asset sale; free cash flow was $4.1M for the quarter, marking the fourth consecutive quarter of positive operating cash flow.
GES sales grew 55% sequentially in Q3 and are expected to grow in Q4 and FY26 based on a strong backlog; PMT sales rose 7% YoY, with combined GES and PMT backlog at $95M, and management expects continued growth despite near-term market uncertainty.
Proceeds from the healthcare divestiture will be invested in high-growth areas, especially Green Energy Solutions; management is prioritizing internal investments in engineering and business development, with M&A strategy development expected later in FY26, and sees opportunities from U.S. manufacturing policies and global energy storage market growth (projected 21% CAGR through 2032).